“…Incorporation of both TFM and an indoline residue unexpectedly gives a less potent captopril analog, 2-(R,S). Enalaprilat analogs derived from replacement of the alanine residue, with (S)-TFM-norvaline (L-TFNV) [5], 3-(SS,S), and (S)-TFM-norleucine (t.-TFNL) [5] residues, 4-(S,S,S), gave moderately potent peptides. The other diastereomers of 2-4 exhibited 2-5 order of magnitude weaker activities as predicted.…”